The first stop for professional medicines advice

Supply

40 results

Applied filters

Transcribing in the patient's home with healthcare input

22 February 2022Consideration needs to be given to the risk factors particularly associated with transcribing in the patient's home with healthcare input

Acute settings and transcribing

22 February 2022Consideration needs to be given to the risk factors particularly associated with transcribing in acute settings

Prescribing available medicines to treat ADHD

27 September 2023The availability of medicines used to treat Attention Deficit Hyperactivity Disorder (ADHD) varies currently. Supply content is maintained regularly by DHSC.

Prescribing available HRT products

28 April 2022Hormone Replacement Therapy availability varies currently. Check for available products and keep up-to-date. Supply content is maintained regularly by DHSC.

Understanding the falsified medicines directive

9 March 2023An overview of the changes to the requirements for medicines ‘safety features’ following the UK’s departure from the EU

Labelling and packaging of unlicensed medicines (Specials): best practice guidance for the NHS

1 March 2022National guidance from NHSE/I to reduce LASA errors and improve patient safety when considering requirements for unlicensed specials medicines

Patient Group Directions (PGDs) and abortifacients

14 September 2020This article advises on the legal position on the supply/administration of abortifacients under PGDs.

Mixing of medicines and Patient Group Directions

9 September 2020This article provides advice on the legal considerations required when considering mixing medicines to be supplied or administered under a PGD

Labelling medicines supplied without a prescription

9 September 2020Advice on the legal labelling requirements for Prescription Only Medicines and Pharmacy Medicines supplied under a patient group direction or legal exemption.

Moving COVID-19 vaccines legally within the NHS

21 June 2021Moving vaccines within and between NHS organisations is subject to regulatory constraints. Senior pharmacists need to be able to advise on appropriate practice
admin